Development and initial psychometric properties of the timed upper limb assessment in older adults with Parkinson's.
Kristie Harper, Angela Jacques, Melanie Burton and 2 others
PMID 40901645WHAT IT FOUND
A new 10-item timed hand and arm test took people with Parkinson's 22.2 seconds on average, against 16.8 seconds for controls, and times rose with disease stage.
Two raters scored the same videos alike, but no one has yet re-tested the same person.
Key findings
01Adults with Parkinson's took longer than controls on the timed upper limb assessment overall (22.2 seconds on average against 16.8 seconds), and on every item except pouring liquid and handling a tablet.
02Completion times rose with more advanced disease: the overall time was 18.3 seconds at Hoehn and Yahr stage 1, 22.5 at stage 2 and 26.0 at stage 3, and every item except unscrewing jar lids differed significantly across stages.
03Two senior occupational therapists who independently scored the same video recordings agreed closely on every item, with agreement values above 0.9.
STILL TO COME
How it was doneWhat they foundWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Everyone was recruited from a single outpatient clinic, using a convenience sample, in one western population aged 58 to 93, which the authors say limits how far the results generalise. The senior occupational therapist who carried out the assessments had also recruited all the patients, which the authors flag as a source of bias. The authors report no test-retest reliability, no discriminant validity and no responsiveness data, so it is unknown whether the test gives the same score twice or detects real change over time. Medication use was recorded but its effect on performance was not examined, and the time of day people were tested was not standardised, so a slow score may reflect the timing of medication rather than upper limb function. The Parkinson's group was mostly in the early stages and cognitively intact (41.8% at Hoehn and Yahr stage 1, none at stage 4 or 5, mean MoCA 25.2 and MMSE 28.0), so these times say little about people with advanced disease or dementia. No analysis was done by type of Parkinson's presentation. Item times varied enormously between individuals, so a single cut-off may not fit one person well. The authors also note that further validation in larger and more diverse populations is needed.
Declared interests
The authors declared no conflicts of interest. The work was supported by a teaching and research grant from the School of Allied Health at Curtin University. There is no industry funding, but the assessment was developed by occupational therapists working in the same clinic where it was then tested.
The easy way to misread this
Do not read the authors' conclusion that the test is reliable and valid as meaning it is ready to use. It was developed and tested in one clinic by the therapists who then assessed patients they had recruited themselves, there is no data on whether the same person scores the same twice, and the way the items group together in people with Parkinson's did not hold in the healthy comparison group. It is an early-stage measurement tool, not an established one.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →